Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 20 min ago
Peer-reviewedCC BY-NC-ND 4.0In Vivo

Definitive Hypofractionated Radiotherapy in Elderly Patients With Non-melanoma Skin Cancer: Predicting Complete Response Using a Machine Learning-based Approach

4 affiliations
  1. 1Department of Radiotherapy, Policlinico Umberto I, Department of Radiological, Oncological and Pathological Sciences, “Sapienza” University of Rome, Rome, Italy
  2. 2Radiotherapy Department S.Croce & Carle Teaching Hospital, Cuneo, Italy
  3. 3Department of Radiation Oncology, Ospedale dell’Angelo, Venice, Italy
  4. 4Department of Radiotherapy Santa Maria Addolorata Hospital, Rome, Italy

Abstract

Background/Aim: This study aimed to develop a classification tree model to predict clinical complete response (cCR) after definitive hypofractionated RT in elderly patients with non-melanoma (basal and squamous cell carcinoma) skin cancer based on pre-treatment clinical parameters.

Patients and Methods: Data from elderly patients (aged ≥ 70 years) with histologically proven non-melanoma skin cancer lesion(s) were reviewed. All lesions were treated with definitive hypofractionated RT. A decision tree methodology was applied to define significant pre-treatment parameters influencing the cCR rate. The data set included seven predictor variables (location, histology, T stage, diameter, bleeding, pain, previous treatment) and a dependent variable (cCR). The analysis was conducted using open-source R software. Important explanatory variables were selected using the random forest approach. A classification tree that optimally partitioned patients according to cCR was then built.

Results: A total of 121 patients with 145 non-melanoma skin cancer lesions were identified between January 2015 and December 2023. The cCR rate after treatment was 78.6%. The three most important variables identified were T stage, location and pain at diagnosis. Based on these explanatory variables, patients were partitioned in five groups. Of these groups, three experienced cCR rates ranging from 69% to 88% and two experienced cCR rates lower than 15%.

Conclusion: The proposed classification tree could serve as a valuable tool to guide future research in the field of non-melanoma skin cancer. The decision tree method may be an effective approach to partition elderly patients with non-melanoma skin cancer based on key clinical parameters.

Related

  1. Prognostic Significance of the ESTRO/EORTC Classification of Oligometastatic Disease for Colorectal Cancer Patients With Uncommon Metastases Treated With Definitive Radiotherapy
    TAO-WEI KE, WILLIAM TZU-LIANG CHEN, SHENG-CHI CHANG +9
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  2. Case Report: Definitive radiotherapy for intrathyroidal thymic carcinoma with neuroendocrine differentiation
    Jia Du, Jiankai Wang, Jianbing Song +3
    Frontiers in oncologyPeer-reviewedCC BYFull textNeurologyEurope PMCCrossref
  3. Ablative ultra-hypofractionated radiotherapy with surgical GI exclusion as a “functional spacer” for pancreatic cancer: a phase I safety and feasibility study
    Yupeng Di, Tingyi Xia, Yingjie Wang +1
    BMC CancerPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  4. Overall treatment time and oncologic outcomes after definitive radiotherapy or chemoradiotherapy for cervical cancer: a systematic review and meta-analysis
    Yingding Ruan, Yun Li, Dan Wu +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefDOAJ
  5. Definitive radiotherapy versus surgery after neoadjuvant immunochemotherapy for locally advanced esophageal squamous cell carcinoma: a propensity score-matched study of efficacy and safety
    Qiuying An, Yage Jia, Menglu Liu +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMCCrossrefEurope PMC
BibTeX
@article{felice2026definitive,
  title = {{Definitive Hypofractionated Radiotherapy in Elderly Patients With Non-melanoma Skin Cancer: Predicting Complete Response Using a Machine Learning-based Approach}},
  author = {FRANCESCA DE FELICE and LAVINIA SPINELLI and PAOLA CRITELLI and MELISSA SCRICCIOLO and DANIELA MUSIO and ANNALISA MAGNANTE and STEFANIA MARTINI and GIUSEPPE MINNITI and ANNA MERLOTTI},
  journal = {In Vivo},
  year = {2026},
  month = oct,
  doi = {10.21873/invivo.14507},
  url = {https://doi.org/10.21873/invivo.14507},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Definitive Hypofractionated Radiotherapy in Elderly Patients With Non-melanoma Skin Cancer: Predicting Complete Response Using a Machine Learning-based Approach
AU  - FRANCESCA DE FELICE
AU  - LAVINIA SPINELLI
AU  - PAOLA CRITELLI
AU  - MELISSA SCRICCIOLO
AU  - DANIELA MUSIO
AU  - ANNALISA MAGNANTE
AU  - STEFANIA MARTINI
AU  - GIUSEPPE MINNITI
AU  - ANNA MERLOTTI
PY  - 2026
DA  - 2026/10/29
JO  - In Vivo
DO  - 10.21873/invivo.14507
UR  - https://doi.org/10.21873/invivo.14507
AB  - Background/Aim: This study aimed to develop a classification tree model to predict clinical complete response (cCR) after definitive hypofractionated RT in elderly patients with non-melanoma (basal and squamous cell carcinoma) skin cancer based on pre-treatment clinical parameters.  Patients and Methods: Data from elderly patients (aged ≥ 70 years) with histologically proven non-melanoma skin cancer lesion(s) were reviewed. All lesions were treated with definitive hypofractionated RT. A decision tree methodology was applied to define significant pre-treatment parameters influencing the cCR rate. The data set included seven predictor variables (location, histology, T stage, diameter, bleeding, pain, previous treatment) and a dependent variable (cCR). The analysis was conducted using open-source R software. Important explanatory variables were selected using the random forest approach. A classification tree that optimally partitioned patients according to cCR was then built.  Results: A total of 121 patients with 145 non-melanoma skin cancer lesions were identified between January 2015 and December 2023. The cCR rate after treatment was 78.6%. The three most important variables identified were T stage, location and pain at diagnosis. Based on these explanatory variables, patients were partitioned in five groups. Of these groups, three experienced cCR rates ranging from 69% to 88% and two experienced cCR rates lower than 15%.  Conclusion: The proposed classification tree could serve as a valuable tool to guide future research in the field of non-melanoma skin cancer. The decision tree method may be an effective approach to partition elderly patients with non-melanoma skin cancer based on key clinical parameters.
SN  - 0258-851X
SN  - 1791-7549
ER  -